logo

For the Inventor, By the Inventor

Hegenheim, France

Sebastien Jacquier

This inventor holds 6 USPTO granted patents. Top assignee: Novartis Ag. Active years: 2014-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sebastien Jacquier. Retrieved from https://idiyas.com/inventor/sebastien-jacquier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 9.3

ph-index = 3

Forward Citations = 19(Granted Patents)


Company Filing History:

goldMedal6 out of 3,977 
 
Novartis Ag
 patents

Years Active: 2014-2020

Loading Chart...
6 patents (USPTO):Explore Patents
1. 10683287 - Heterocyclic derivatives and their use in the treatment of neurological disorders (2020-06-16),
2. 10301296 - Heterocyclic derivatives and their use in the treatment of neurological disorders (2019-05-28),
3. 10035794 - Heterocyclic derivatives and their use in the treatment of neurological disorders (2018-07-31),
4. 9550758 - Heterocyclic derivatives and their use in the treatment of neurological disorders (2017-01-24),
5. 9284284 - Oxazine derivatives and their use in the treatment of disease (2016-03-15),
6. 8865712 - Heterocyclic derivatives and their use in the treatment of neurological disorders (2014-10-21),

Title: The Innovative Contributions of Sebastien Jacquier

Introduction

Sebastien Jacquier is a notable inventor based in Hegenheim, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for treating neurological disorders. With a total of 6 patents to his name, Jacquier's work is paving the way for advancements in medical treatments.

Latest Patents

Among his latest patents, Jacquier has focused on heterocyclic derivatives and their applications in treating neurological disorders. His inventions relate to novel heterocyclic compounds that are designed to be used as medicaments, particularly for conditions such as Alzheimer's Disease and diabetes. These compounds work through the inhibition of BACE-1 or BACE-2, showcasing Jacquier's commitment to addressing critical health issues.

Career Highlights

Sebastien Jacquier is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development efforts. His innovative approach and dedication to improving patient outcomes have made him a valuable asset to the company.

Collaborations

Jacquier has worked alongside talented colleagues, including Konstanze Hurth and Rainer Machauer. These collaborations have fostered an environment of creativity and innovation, further enhancing the impact of their collective work in the pharmaceutical industry.

Conclusion

Sebastien Jacquier's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in the treatment of neurological disorders, making a significant difference in the lives of many.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…